Cisplatin selectively downregulated the frequency and immunoinhibitory function of myeloid-derived suppressor cells in a murine B16 melanoma model
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cisplatin selectively downregulated the frequency and immunoinhibitory function of myeloid-derived suppressor cells in a murine B16 melanoma model
Authors
Keywords
Chemotherapeutic drugs, Cisplatin, Immunomodulation, Myeloid-derived suppressor cells
Journal
IMMUNOLOGIC RESEARCH
Volume 64, Issue 1, Pages 160-170
Publisher
Springer Nature
Online
2015-11-21
DOI
10.1007/s12026-015-8734-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New clinical advances in immunotherapy for the treatment of solid tumours
- (2015) Valentina A. Zavala et al. IMMUNOLOGY
- Challenges and future perspectives of T cell immunotherapy in cancer
- (2015) Maria Teresa P. de Aquino et al. IMMUNOLOGY LETTERS
- The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
- (2015) Thomas F. Gajewski SEMINARS IN ONCOLOGY
- Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment
- (2015) Wei Pan et al. TUMOR BIOLOGY
- Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy
- (2015) Oana Draghiciu et al. OncoImmunology
- Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
- (2015) Annie A Wu et al. OncoImmunology
- Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy
- (2014) Michelle N. Messmer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge
- (2014) A. Makkouk et al. CANCER RESEARCH
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
- (2014) Hong Qin et al. NATURE MEDICINE
- Effectiveness and Safety of Chemotherapy Combined with Dendritic Cells Co-Cultured with Cytokine-Induced Killer Cells in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
- (2014) Rui-xian Han et al. PLoS One
- Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications
- (2014) C. Marcela Diaz-Montero et al. SEMINARS IN ONCOLOGY
- Myeloid-derived suppressor cells
- (2014) Dinesh Chandra et al. OncoImmunology
- Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models
- (2013) Maria Jure-Kunkel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hampering Immune Suppressors
- (2013) Sabrin Husein Albeituni et al. CANCER JOURNAL
- Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
- (2013) D. Alizadeh et al. CANCER RESEARCH
- Myeloid-derived suppressor cells in cancer: recent progress and prospects
- (2013) Yazan S Khaled et al. IMMUNOLOGY AND CELL BIOLOGY
- Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines
- (2013) A Q Butt et al. ONCOGENE
- Preconditioning Chemotherapy with Cisplatin Enhances the Antitumor Activity of Cytokine-Induced Killer Cells in a Murine Melanoma Model
- (2012) Jing Chen et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine
- (2012) Shiwen Peng et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer
- (2012) Stephanie K. Bunt et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Aptamer-Mediated Blockade of IL4R Triggers Apoptosis of MDSCs and Limits Tumor Progression
- (2012) F. Roth et al. CANCER RESEARCH
- Myeloid-derived Suppressor Cells in Cancer Patients
- (2012) Alberto J. Montero et al. JOURNAL OF IMMUNOTHERAPY
- Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
- (2011) Paola Filipazzi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Role of myeloid-derived suppressor cells in tumor immunotherapy
- (2011) François Martin et al. Immunotherapy
- The restoration of myeloid-derived suppressor cells as functional antigen-presenting cells by NKT cell help and all-trans-retinoic acid treatment
- (2011) Jung-Mi Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Cisplatin pretreatment enhances anti-tumor activity of cytokine-induced killer cells
- (2011) Xiang Huang WORLD JOURNAL OF GASTROENTEROLOGY
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers
- (2010) K. N. Kodumudi et al. CLINICAL CANCER RESEARCH
- Preconditioning chemotherapy with paclitaxel and cisplatin enhances the antitumor activity of cytokine induced-killer cells in a murine lung carcinoma model
- (2010) Xiang Huang et al. INTERNATIONAL JOURNAL OF CANCER
- Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine
- (2009) H.-J. Ko et al. JOURNAL OF IMMUNOLOGY
- IL4Rα + Myeloid-Derived Suppressor Cell Expansion in Cancer Patients
- (2009) Susanna Mandruzzato et al. JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search